Taiyen Biotech Co Ltd (1737) — Long-term Investment Intensity

Latest as of December 2019: 0.6%

Taiyen Biotech Co Ltd (1737) has a Long-term Investment Intensity of 0.6% as of December 2019. Long-term investments of NT$43.53 Million represent 0.6% of total assets of NT$7.60 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Taiyen Biotech Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

0.6%
LT Investments / Total Assets

Long-term Investments

NT$43.53 Million
TWD

Total Assets

NT$7.60 Billion
TWD

Country

Taiwan
TW

Taiyen Biotech Co Ltd Long-term Investment Intensity (2013–2019)

This chart shows how Taiyen Biotech Co Ltd's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 0.6%, reflecting long-term investments of NT$43.53 Million against total assets of NT$7.60 Billion TWD. For the complete balance sheet picture, see Taiyen Biotech Co Ltd asset portfolio.

Annual Long-term Investment Intensity for Taiyen Biotech Co Ltd (2013–2019)

The table below presents the year-by-year Long-term Investment Intensity for Taiyen Biotech Co Ltd from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read 1737 current and long-term liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (TWD) Total Assets Change (pp)
2019 0.6% NT$43.53 Million NT$7.60 Billion ▲ +0.4 pp
2018 0.2% NT$11.69 Million NT$7.33 Billion ▼ -0.4 pp
2017 0.5% NT$37.91 Million NT$7.25 Billion ▼ -0.4 pp
2016 1.0% NT$67.24 Million NT$7.05 Billion ▼ -3.6 pp
2015 4.5% NT$310.94 Million NT$6.85 Billion ▲ +0.3 pp
2014 4.2% NT$283.62 Million NT$6.74 Billion ▲ +0.3 pp
2013 3.9% NT$243.54 Million NT$6.17 Billion
pp = percentage points